Development and validation of nomograms using photoacoustic imaging and 2D ultrasound to predict breast nodule benignity and malignancy
Postgraduate Medical Journal · 2024
DOI: 10.1093/postmj/qgad146 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Postgraduate Medical Journal, 2024. Verfasst von Jing Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Department, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern Uni…. Hauptthemen laut MEDLINE: Photoacoustic Techniques, Breast Neoplasms, Nomograms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Project of Shenzhen People's Hospital, Clinical Research Project of Shenzhen People’s Hospital.
Abstract (Originalsprache)
Background
The application of photoacoustic imaging (PAI), utilizing laser-induced ultrasound, shows potential in assessing blood oxygenation in breast nodules. However, its effectiveness in distinguishing between malignant and benign nodules remains insufficiently explored.
Purpose
This study aims to develop nomogram models for predicting the benign or malignant nature of breast nodules using PAI.
Method
A prospective cohort study enrolled 369 breast nodules, subjecting them to PAI and ultrasound examination. The training and testing cohorts were randomly divided into two cohorts in a ratio of 3:1. Based on the source of the variables, three models were developed, Model 1: photoacoustic-BIRADS+BMI + blood oxygenation, Model 2: BIRADS+Shape+Intranodal blood (Doppler) + BMI, Model 3: photoacoustic-BIRADS+BIRADS+ Shape+Intranodal blood (Doppler) + BMI + blood oxygenation. Risk factors were identified through logistic regression, resulting in the creation of three predictive models. These models were evaluated using calibration curves, subject receiver operating characteristic (ROC), and decision curve analysis.
Results
The area under the ROC curve for the training cohort was 0.91 (95% confidence interval, 95% CI: 0.88–0.95), 0.92 (95% CI: 0.89–0.95), and 0.97 (95% CI: 0.96–0.99) for Models 1–3, and the ROC curve for the testing cohort was 0.95 (95% CI: 0.91–0.98), 0.89 (95% CI: 0.83–0.96), and 0.97 (95% CI: 0.95–0.99) for Models 1–3.
Conclusions
The calibration curves demonstrate that the model’s predictions agree with the actual values. Decision curve analysis suggests a good clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ultrasound Department, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong 518020, China.
- Ultrasound Department, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong 518020, China.
Förderung
- Clinical Research Project of Shenzhen People's Hospital
- Clinical Research Project of Shenzhen People’s Hospital
Zitieren
APA
Chen, J., Huang, Z., Luo, H., Li, G., Ding, Z., Tian, H., Tang, S., Mo, S., Xu, J., Wu, H., & Dong, F. (2024). Development and validation of nomograms using photoacoustic imaging and 2D ultrasound to predict breast nodule benignity and malignancy. Postgraduate Medical Journal. https://doi.org/10.1093/postmj/qgad146
Vancouver
Chen J, Huang Z, Luo H, Li G, Ding Z, Tian H, et al. Development and validation of nomograms using photoacoustic imaging and 2D ultrasound to predict breast nodule benignity and malignancy. Postgraduate Medical Journal. 2024. doi:10.1093/postmj/qgad146
BibTeX
@article{Chen2024,
author = {Chen, Jing and Huang, Zhibin and Luo, Hui and Li, Guoqiu and Ding, Zhimin and Tian, Hongtian and Tang, Shuzhen and Mo, Sijie and Xu, Jinfeng and Wu, Huaiyu and Dong, Fajin},
title = {Development and validation of nomograms using photoacoustic imaging and 2D ultrasound to predict breast nodule benignity and malignancy},
journal = {Postgraduate Medical Journal},
year = {2024},
doi = {10.1093/postmj/qgad146}
}
EUVIMED